Synergistic Anxiolytic Effects of Linalool and Sesamol Co-Treatment on Swiss Albino Mice: A Potential GABAergic Intervention
- PMID: 39729049
- DOI: 10.1002/syn.70003
Synergistic Anxiolytic Effects of Linalool and Sesamol Co-Treatment on Swiss Albino Mice: A Potential GABAergic Intervention
Abstract
Sesamol (SES) and linalool (LIN) are aromatic compounds that have neuroprotective effects. The main purpose of this study is to evaluate the anxiolytic activity of LIN and SES co-treatment on Swiss albino mice and analyze its possible mechanism through in silico study. In this sense, the mice were given the gamma-aminobutyric acid type A receptors (GABAA) agonist diazepam (DZP; 3 mg/kg, p.o.) as a positive control. A vehicle (10 mL/kg) was served as control. The tested chemicals, single-dose LIN (50 mg/kg) and SES (50 mg/kg), as well as a combination (LIN + SES) and (DZP + LIN + SES), were administered orally in order to conduct several behavioral tests, including open-field, swings box, hole-crossing, and dark-resident time tests. Further, molecular docking studies of LIN, SES, and DZP were carried out through different software. The results showed that LIN and SES individually have significant anxiolytic-like activity in mice. Further, when LIN was combined with SES and with (SES + DZP), it exhibited a relatively lower locomotor activity in mice compared to individual treatment groups, indicating a synergistic action. In addition, the molecular docking analysis revealed that LIN and SES have a moderate binding affinity (-5.0 and -5.1 kcal/mol) toward the GABAA receptor α3 subunit. In conclusion, our findings suggest that LIN and SES exerted synergistic anxiolytic activity on Swiss albino mice, possibly through the GABAergic interaction pathways.
Keywords: GABAA receptor; anxiety; linalool; molecular docking; sesamol.
© 2024 Wiley Periodicals LLC.
Similar articles
-
Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway.Drug Dev Res. 2024 Dec;85(8):e70028. doi: 10.1002/ddr.70028. Drug Dev Res. 2024. PMID: 39635782
-
Anxiolytic Activity of Morellic Acid: Modulation of Diazepam's Anxiolytic Effects, Possibly Through GABAergic Interventions.CNS Neurosci Ther. 2025 Feb;31(2):e70276. doi: 10.1111/cns.70276. CNS Neurosci Ther. 2025. PMID: 39957689 Free PMC article.
-
Anxiolytic Efficacy of Indirubin: In Vivo Approach Along with Receptor Binding Profiling and Molecular Interaction with GABAergic Pathways.ChemistryOpen. 2025 Feb;14(2):e202400290. doi: 10.1002/open.202400290. Epub 2024 Oct 25. ChemistryOpen. 2025. PMID: 39460441 Free PMC article.
-
Anxiogenic-like effects of coumarin, possibly through the GABAkine interaction pathway: Animal studies with in silico approaches.Behav Brain Res. 2025 Mar 5;480:115392. doi: 10.1016/j.bbr.2024.115392. Epub 2024 Dec 10. Behav Brain Res. 2025. PMID: 39667645
-
Tangeretin enhances sedative activity of diazepam in Swiss mice through GABAA receptor interaction: In vivo and in silico approaches.Neuroscience. 2025 Apr 19;572:1-10. doi: 10.1016/j.neuroscience.2025.03.004. Epub 2025 Mar 4. Neuroscience. 2025. PMID: 40049390
References
-
- Akbor, M. S., M. H. Bappi, A. A. S. Prottay, et al. 2023. “Synergistic Hypnotic Effects of Sesamol and Thymol Possibly Through GABAergic Interaction Pathway: In Vivo and In Silico Studies.” Journal of Biological Regulators and Homeostatic Agents 37, no. 11: 6419–6435.
-
- Aman, U., F. Subhan, M. Shahid, et al. 2016. “Passiflora Incarnata Attenuation of Neuropathic Allodynia and Vulvodynia Apropos GABA‐Ergic and Opioidergic Antinociceptive and Behavioural Mechanisms.” BMC Complementary and Alternative Medicine 16: 1–17.
-
- de Moura do Amaral, M. P., M. P. da Silva Junior, F. das Chagas Alves Lima, S. J. C. Gutierrez, D. D. R. Arcanjo, and R. D. C. M. Oliveira. 2023. “Anxiolytic/Sedative Effect of Monoterpene (–)‐Borneol in Mice and In Silico Molecular Interaction With GABAA Receptor.” Future Pharmacology 3, no. 1: 132–141.
-
- Aprotosoaie, A. C., M. Hăncianu, I. I. Costache, and A. Miron. 2014. “Linalool: A Review on a Key Odorant Molecule With Valuable Biological Properties.” Flavour and Fragrance Journal 29, no. 4: 193–219.
-
- Atack, J. R. 2005. “The Benzodiazepine Binding Site of GABAA Receptors as a Target for the Development of Novel Anxiolytics.” Expert Opinion on Investigational Drugs 14, no. 5: 601–618.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources